Jie Cao

Downregulation of <scp>m⁶A</scp> reader <scp>YTHDC2</scp> promotes tumor progression and predicts poor prognosis in non‐small cell lung cancer

Shulei Sun, Maoli Liang, Qian Zhang et al. · Thoracic Cancer · 2020 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +17

The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy

Siwen Li, Jingyi Qin, Caiping Tian et al. · Oncotarget · 2014 · 34 citations · Full text

Medicine, Oncology, Pharmacology +14

Multifunctional near-infrared light-triggered biodegradable micelles for chemo- and photo-thermal combination therapy

Jie Cao, Dan Chen, Shanshan Huang et al. · Oncotarget · 2016 · 30 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Isorhapontigenin alleviates lipopolysaccharide-induced acute lung injury via modulating Nrf2 signaling

Yao Peiyu, Zhuo Zhang, Jie Cao · Respiratory Physiology & Neurobiology · 2021 · 20 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Application of metagenomic next-generation sequencing (mNGS) combined with rapid on-site cytological evaluation (ROSCE) for the diagnosis of Chlamydia psittaci pneumonia.

Qian Zhang, Shuo Li, Wei Zhou et al. · PubMed · 2021 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17